Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 99

1.

Perspectives on the impact of painful diabetic peripheral neuropathy in a multicultural population.

Eichholz M, Alexander AH, Cappelleri JC, Hlavacek P, Parsons B, Sadosky A, Tuchman MM.

Clin Diabetes Endocrinol. 2017 Dec 28;3:12. doi: 10.1186/s40842-017-0051-2. eCollection 2017.

2.

The prevalence of probable neuropathic pain in the US: results from a multimodal general-population health survey.

DiBonaventura MD, Sadosky A, Concialdi K, Hopps M, Kudel I, Parsons B, Cappelleri JC, Hlavacek P, Alexander AH, Stacey BR, Markman JD, Farrar JT.

J Pain Res. 2017 Nov 1;10:2525-2538. doi: 10.2147/JPR.S127014. eCollection 2017.

3.

Interpreting the Effectiveness of Opioids and Pregabalin for Pain Severity, Pain Interference, and Fatigue in Fibromyalgia Patients.

Davis F, Gostine M, Roberts BA, Risko R, Cappelleri JC, Sadosky A.

Pain Pract. 2017 Oct 24. doi: 10.1111/papr.12651. [Epub ahead of print]

PMID:
29064627
4.

A systematic review of the effectiveness of policies restricting access to pregabalin.

Stacey BR, Liss J, Behar R, Sadosky A, Parsons B, Masters ET, Hlavacek P.

BMC Health Serv Res. 2017 Aug 25;17(1):600. doi: 10.1186/s12913-017-2503-x.

5.

Neuropathic pain: a narrative review of etiology, assessment, diagnosis, and treatment for primary care providers.

McCarberg B, D'Arcy Y, Parsons B, Sadosky A, Thorpe A, Behar R.

Curr Med Res Opin. 2017 Aug;33(8):1361-1369. doi: 10.1080/03007995.2017.1321532. Epub 2017 Jun 5.

PMID:
28422517
6.

Clinical Characteristics of Fibromyalgia in a Chronic Pain Population.

Gostine M, Davis F, Roberts BA, Risko R, Asmus M, Cappelleri JC, Sadosky A.

Pain Pract. 2018 Jan;18(1):67-78. doi: 10.1111/papr.12583. Epub 2017 May 30.

PMID:
28419751
7.

Measurement properties of painDETECT: Rasch analysis of responses from community-dwelling adults with neuropathic pain.

Packham TL, Cappelleri JC, Sadosky A, MacDermid JC, Brunner F.

BMC Neurol. 2017 Mar 4;17(1):48. doi: 10.1186/s12883-017-0825-2.

8.

Discriminating between neuropathic pain and sensory hypersensitivity using the Chronic Pain Questions (CPQ).

Coyne KS, Currie BM, Donevan S, Cappelleri JC, Hegeman-Dingle R, Abraham L, Thompson C, Sadosky A, Brodsky M.

Postgrad Med. 2017 Jan;129(1):22-31. doi: 10.1080/00325481.2017.1267538. Epub 2016 Dec 20.

PMID:
27901398
9.

Humanistic and economic burden of fibromyalgia in Japan.

Lee LK, Ebata N, Hlavacek P, DiBonaventura M, Cappelleri JC, Sadosky A.

J Pain Res. 2016 Nov 4;9:967-978. eCollection 2016. Erratum in: J Pain Res. 2016 Dec 05;9:1161.

10.

Psychometric validation of the electronic chronic pain questions (eCPQ) in a primary care setting.

Coyne KS, Currie BM, Donevan S, Brodsky M, Asmus MJ, Krichbaum DW, Cappelleri JC, Hegeman-Dingle R, Sadosky A, Whipple SZ, Burbridge C, Mulhem E, Hillenberg JB.

Curr Med Res Opin. 2017 Jan;33(1):137-148. Epub 2016 Nov 10.

PMID:
27829303
11.

Costs and Work Loss Burden of Diagnosed Opioid Abuse Among Employees on Workers Compensation or Short-term Disability.

Johnston SS, Alexander AH, Masters ET, Mardekian J, Semel D, Malangone-Monaco E, Riehle E, Wilson K, Sadosky A.

J Occup Environ Med. 2016 Nov;58(11):1087-1097.

PMID:
27820758
12.

Effects of Pregabalin in Patients with Neuropathic Pain Previously Treated with Gabapentin: A Pooled Analysis of Parallel-Group, Randomized, Placebo-controlled Clinical Trials.

Markman JD, Jensen TS, Semel D, Li C, Parsons B, Behar R, Sadosky AB.

Pain Pract. 2017 Jul;17(6):718-728. doi: 10.1111/papr.12516. Epub 2016 Dec 1.

PMID:
27611736
13.

Characterizing individual painDETECT symptoms by average pain severity.

Sadosky A, Koduru V, Bienen EJ, Cappelleri JC.

Clinicoecon Outcomes Res. 2016 Jul 26;8:361-6. doi: 10.2147/CEOR.S105402. eCollection 2016.

14.

Participant Preferences for Pharmacologic Chronic Pain Treatment Trial Characteristics: An ACTTION Adaptive Choice-Based Conjoint Study.

Smith SM, Gewandter JS, Kitt RA, Markman JD, Vaughan JA, Cowan P, Kopecky EA, Malamut R, Sadosky A, Tive L, Turk DC, Dworkin RH.

J Pain. 2016 Nov;17(11):1198-1206. doi: 10.1016/j.jpain.2016.07.008. Epub 2016 Aug 20.

PMID:
27555429
15.

Mapping painDETECT, a neuropathic pain screening tool, to the EuroQol (EQ-5D-3L).

Cappelleri JC, Koduru V, Bienen EJ, Sadosky A.

Qual Life Res. 2017 Feb;26(2):467-477. doi: 10.1007/s11136-016-1379-2. Epub 2016 Aug 2.

PMID:
27485915
16.

Characterizing neuropathic pain profiles: enriching interpretation of painDETECT.

Cappelleri JC, Koduru V, Bienen EJ, Sadosky A.

Patient Relat Outcome Meas. 2016 Jul 5;7:93-9. doi: 10.2147/PROM.S101892. eCollection 2016.

17.

Pain relief and functional improvement in patients with neuropathic pain associated with spinal cord injury: an exploratory analysis of pregabalin clinical trials.

Sadosky A, Parsons B, Emir B, Nieshoff EC.

J Pain Res. 2016 Jun 15;9:405-16. doi: 10.2147/JPR.S97770. eCollection 2016.

18.

Using Random Forest Models to Identify Correlates of a Diabetic Peripheral Neuropathy Diagnosis from Electronic Health Record Data.

DuBrava S, Mardekian J, Sadosky A, Bienen EJ, Parsons B, Hopps M, Markman J.

Pain Med. 2017 Jan 1;18(1):107-115. doi: 10.1093/pm/pnw096.

PMID:
27252307
19.

Impact of a Novel Cost-Saving Pharmacy Program on Pregabalin Use and Health Care Costs.

Martin C, Odell K, Cappelleri JC, Bancroft T, Halpern R, Sadosky A.

J Manag Care Spec Pharm. 2016 Feb;22(2):132-44. doi: 10.18553/jmcp.2016.15180. Epub 2015 Dec 14.

20.

Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan.

Igarashi A, Akazawa M, Murata T, Taguchi T, Sadosky A, Ebata N, Willke R, Fujii K, Doherty J, Kobayashi M.

Clinicoecon Outcomes Res. 2015 Oct 7;7:505-20. doi: 10.2147/CEOR.S89833. eCollection 2015.

Supplemental Content

Loading ...
Support Center